vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and TEXAS CAPITAL BANCSHARES INC (TCBI). Click either name above to swap in a different company.

TEXAS CAPITAL BANCSHARES INC is the larger business by last-quarter revenue ($324.0M vs $164.7M, roughly 2.0× PTC THERAPEUTICS, INC.). TEXAS CAPITAL BANCSHARES INC runs the higher net margin — 22.8% vs -82.0%, a 104.7% gap on every dollar of revenue. On growth, TEXAS CAPITAL BANCSHARES INC posted the faster year-over-year revenue change (15.5% vs -22.7%). Over the past eight quarters, TEXAS CAPITAL BANCSHARES INC's revenue compounded faster (10.2% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

PTCT vs TCBI — Head-to-Head

Bigger by revenue
TCBI
TCBI
2.0× larger
TCBI
$324.0M
$164.7M
PTCT
Growing faster (revenue YoY)
TCBI
TCBI
+38.3% gap
TCBI
15.5%
-22.7%
PTCT
Higher net margin
TCBI
TCBI
104.7% more per $
TCBI
22.8%
-82.0%
PTCT
Faster 2-yr revenue CAGR
TCBI
TCBI
Annualised
TCBI
10.2%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PTCT
PTCT
TCBI
TCBI
Revenue
$164.7M
$324.0M
Net Profit
$-135.0M
$73.8M
Gross Margin
Operating Margin
-43.3%
Net Margin
-82.0%
22.8%
Revenue YoY
-22.7%
15.5%
Net Profit YoY
-104.8%
56.8%
EPS (diluted)
$-1.63
$1.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
TCBI
TCBI
Q1 26
$324.0M
Q4 25
$164.7M
$327.5M
Q3 25
$211.0M
$340.4M
Q2 25
$178.9M
$307.5M
Q1 25
$1.2B
$280.5M
Q4 24
$213.2M
$229.6M
Q3 24
$196.8M
$125.3M
Q2 24
$186.7M
$267.0M
Net Profit
PTCT
PTCT
TCBI
TCBI
Q1 26
$73.8M
Q4 25
$-135.0M
$100.7M
Q3 25
$15.9M
$105.2M
Q2 25
$-64.8M
$77.3M
Q1 25
$866.6M
$47.0M
Q4 24
$-65.9M
$71.0M
Q3 24
$-106.7M
$-61.3M
Q2 24
$-99.2M
$41.7M
Operating Margin
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
-43.3%
40.4%
Q3 25
1.4%
40.5%
Q2 25
-19.5%
33.2%
Q1 25
82.5%
21.6%
Q4 24
-76.2%
40.7%
Q3 24
-27.7%
-63.8%
Q2 24
-21.5%
21.9%
Net Margin
PTCT
PTCT
TCBI
TCBI
Q1 26
22.8%
Q4 25
-82.0%
30.7%
Q3 25
7.5%
30.9%
Q2 25
-36.3%
25.2%
Q1 25
73.7%
16.8%
Q4 24
-30.9%
30.9%
Q3 24
-54.2%
-48.9%
Q2 24
-53.1%
15.6%
EPS (diluted)
PTCT
PTCT
TCBI
TCBI
Q1 26
$1.56
Q4 25
$-1.63
$2.11
Q3 25
$0.20
$2.18
Q2 25
$-0.83
$1.58
Q1 25
$10.04
$0.92
Q4 24
$-0.85
$1.43
Q3 24
$-1.39
$-1.41
Q2 24
$-1.29
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
TCBI
TCBI
Cash + ST InvestmentsLiquidity on hand
$1.9B
Total DebtLower is stronger
$878.3M
Stockholders' EquityBook value
$-205.3M
$3.6B
Total Assets
$2.9B
$33.5B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
$1.9B
Q3 25
$1.7B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.1B
Total Debt
PTCT
PTCT
TCBI
TCBI
Q1 26
$878.3M
Q4 25
$620.6M
Q3 25
$620.4M
Q2 25
$620.3M
Q1 25
$660.5M
Q4 24
$660.3M
Q3 24
$660.2M
Q2 24
$660.0M
Stockholders' Equity
PTCT
PTCT
TCBI
TCBI
Q1 26
$3.6B
Q4 25
$-205.3M
$3.6B
Q3 25
$-155.8M
$3.6B
Q2 25
$-206.5M
$3.5B
Q1 25
$-185.8M
$3.4B
Q4 24
$-1.1B
$3.4B
Q3 24
$-1.1B
$3.4B
Q2 24
$-980.2M
$3.2B
Total Assets
PTCT
PTCT
TCBI
TCBI
Q1 26
$33.5B
Q4 25
$2.9B
$31.5B
Q3 25
$2.6B
$32.5B
Q2 25
$2.6B
$31.9B
Q1 25
$2.7B
$31.4B
Q4 24
$1.7B
$30.7B
Q3 24
$1.8B
$31.6B
Q2 24
$1.9B
$29.9B
Debt / Equity
PTCT
PTCT
TCBI
TCBI
Q1 26
0.24×
Q4 25
0.17×
Q3 25
0.17×
Q2 25
0.18×
Q1 25
0.19×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
TCBI
TCBI
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
$-34.3M
$360.2M
Q3 25
$-66.3M
$166.3M
Q2 25
$-58.3M
$63.0M
Q1 25
$870.1M
$368.0K
Q4 24
$-30.0M
$480.1M
Q3 24
$-77.0M
$332.8M
Q2 24
$-71.5M
$33.3M
Free Cash Flow
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
$-36.6M
$347.6M
Q3 25
$-69.7M
$161.3M
Q2 25
$-59.6M
$57.5M
Q1 25
$868.4M
$-2.0M
Q4 24
$-33.8M
$415.2M
Q3 24
$-77.5M
$317.6M
Q2 24
$-78.8M
$11.1M
FCF Margin
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
-22.3%
106.1%
Q3 25
-33.1%
47.4%
Q2 25
-33.3%
18.7%
Q1 25
73.8%
-0.7%
Q4 24
-15.8%
180.9%
Q3 24
-39.4%
253.4%
Q2 24
-42.2%
4.1%
Capex Intensity
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
1.4%
3.8%
Q3 25
1.6%
1.5%
Q2 25
0.7%
1.8%
Q1 25
0.1%
0.9%
Q4 24
1.8%
28.2%
Q3 24
0.3%
12.1%
Q2 24
4.0%
8.3%
Cash Conversion
PTCT
PTCT
TCBI
TCBI
Q1 26
Q4 25
3.58×
Q3 25
-4.17×
1.58×
Q2 25
0.81×
Q1 25
1.00×
0.01×
Q4 24
6.76×
Q3 24
Q2 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons